Specifically, baseline and post-chemotherapy ALDH1 (% positive and intensity), CD44 (% positive and intensity), CD133, CD31, and CD68 were tested for correlation with baseline (pre-chemotherapy) SUVmax, post-chemotherapy SUVmax, % change in SUVmax, diagnosis (synovial vs other), survival, percent viable cells post-chemotherapy, and change in tumor size (Table 1). This evidence concerns the gene CD44 and neoplasm.